Global Radiation Oncology Market Global Report 2026 Market
Healthcare Services

Radiation Oncology Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Radiation Oncology Market By The End Of 2030?

The radiation oncology market size has seen substantial growth in recent years. It is forecast to rise from $8.73 billion in 2025 to $9.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. Historically, this market’s expansion can be ascribed to several factors, including increasing cancer incidence rates, the proliferation of oncology treatment centers, the adoption of external beam radiation therapy, the availability of standardized radiotherapy protocols, and growing investment in cancer care infrastructure.

The radiation oncology market is projected to experience substantial expansion over the coming years, with its valuation anticipated to reach $13.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing integration of personalized oncology treatments, a surge in demand for stereotactic and proton therapies, the broader implementation of AI-assisted treatment planning, a greater emphasis on outpatient cancer care, and heightened investments in sophisticated oncology equipment. Key trends defining this period encompass the growing adoption of image-guided radiation therapy, an increasing application of precision and targeted treatment techniques, the expanding role of AI in treatment planning, the deployment of more advanced linear accelerator installations, and a sharpened focus on reducing radiation exposure to healthy tissues.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23494&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Radiation Oncology Market?

The increasing global incidence of cancer is projected to significantly boost the expansion of the radiation oncology market. The prevalence of cancer is growing due to factors such as aging populations, lifestyle-related risk factors, and improved methods for early detection. Cancer cases are also rising because of increased exposure to risk factors like unhealthy lifestyles and environmental pollutants, which contribute to higher mutation rates and the gradual formation of malignant cells. Radiation oncology utilizes high-energy radiation to destroy cancer cells, reduce tumor size, and support surgical and chemotherapy interventions, with advanced techniques enhancing precision and patient outcomes. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported an estimated **20 million** new cancer cases in **2022**. The WHO/IARC additionally projects that by **2050**, new cancer cases could climb to **35 million**, marking a **77%** increase from **2022** levels. Consequently, the growing burden of cancer is stimulating demand for advanced radiation oncology treatments.

Which Segment Classifications Shape The Radiation Oncology Market?

The radiation oncology market covered in this report is segmented –

1) By Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy

2) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head And Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Other Applications

3) By End-User: Hospitals, Cancer Research Institutes, Other End-Users

Subsegments:

1) By Internal Beam Radiation Therapy: Brachytherapy, Endocavitary Brachytherapy, Interstitial Brachytherapy, Intraluminal Brachytherapy

2) By External Beam Radiation Therapy: 3D Conformal Radiation Therapy (3DCRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Image-Guided Radiation Therapy (IGRT)

How Are Trends Shaping The Direction Of The Radiation Oncology Market?

Major companies within the radiation oncology market are prioritizing the development of advanced radiation therapy systems that incorporate AI-powered imaging and adaptive technologies. This focus is intended to improve treatment precision, minimize side effects, and enhance patient outcomes for a variety of cancer treatment applications. AI-powered radiotherapy involves utilizing artificial intelligence technologies to refine different aspects of radiation therapy, including its planning, imaging, delivery, and monitoring. An illustration of this trend occurred in May 2024, when Elekta, a Sweden-based medical technology company, launched Evo, its latest CT-Linac featuring high-definition AI-enhanced imaging, designed to advance radiation therapy techniques. This adaptable system offers support for both offline and online adaptive radiation therapy, alongside improved standard image-guided radiation therapy, thereby equipping clinicians with greater precision and flexibility to personalize treatments for individual patients. The goal of this innovation is to elevate patient outcomes by optimizing treatment accuracy and adaptability.

Which Companies Are Expanding Their Footprint In The Radiation Oncology Market?

Major companies operating in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, ScandiDos.

Read the full radiation oncology market report here:

https://www.thebusinessresearchcompany.com/report/radiation-oncology-global-market-report

Which Regions Are Projected To Dominate The Radiation Oncology Market In The Coming Years?

North America was the largest region in the radiation oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Radiation Oncology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23494&type=smp

Browse Through More Reports Similar to the Global Radiation Oncology Market 2026, By The Business Research Company

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model